Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy.
Ta-Chen HuangCher-Wei LiangYu-I LiJhe-Cyuan GuoChia-Chi LinYa-Jhen ChenAnn-Lii ChengChih-Hung HsuPublished in: Journal of cancer research and clinical oncology (2021)
PD-L1 expression on tumor and immune cells may have different prognostic value for patients with locally advanced ESCC receiving neoadjuvant CRT. A combination of these two indexes may further improve the prognostic prediction.